Iran: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Iran

The Iranian market for other medicaments for therapeutic or prophylactic uses shrank to $X in 2022, approximately equating the previous year. In general, consumption continues to indicate a perceptible downturn. Over the period under review, the market attained the peak level at $X in 2015; however, from 2016 to 2022, consumption stood at a somewhat lower figure.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Iran

In value terms, production of other medicaments for therapeutic or prophylactic uses shrank slightly to $X in 2022 estimated in export price. In general, production continues to indicate a noticeable descent. The most prominent rate of growth was recorded in 2014 when the production volume increased by X% against the previous year. Over the period under review, production of hit record highs at $X in 2015; however, from 2016 to 2022, production stood at a somewhat lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Iran

In 2022, overseas shipments of other medicaments for therapeutic or prophylactic uses were finally on the rise to reach X tons after three years of decline. Overall, exports continue to indicate a significant increase. The most prominent rate of growth was recorded in 2014 with an increase of X% against the previous year. The exports peaked at X tons in 2015; however, from 2016 to 2022, the exports remained at a lower figure.

In value terms, exports of other medicaments for therapeutic or prophylactic uses rose significantly to $X in 2022. Over the period under review, exports posted a significant expansion. The pace of growth appeared the most rapid in 2014 with an increase of X%. Over the period under review, the exports of attained the maximum at $X in 2015; however, from 2016 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

Tajikistan (X tons) was the main destination for exports of other medicaments for therapeutic or prophylactic uses from Iran, accounting for a X% share of total exports. Moreover, exports of other medicaments for therapeutic or prophylactic uses to Tajikistan exceeded the volume sent to the second major destination, Azerbaijan (X tons), threefold.

From 2012 to 2022, the average annual rate of growth in terms of volume to Tajikistan totaled X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Azerbaijan (X% per year) and Tunisia (X% per year).

In value terms, Azerbaijan ($X), Tunisia ($X) and Tajikistan ($X) appeared to be the largest markets for other medicaments for therapeutic or prophylactic uses exported from Iran worldwide, together comprising X% of total exports.

Azerbaijan, with a CAGR of X%, saw the highest rates of growth with regard to the value of exports, in terms of the main countries of destination over the period under review, while shipments for the other leaders experienced mixed trend patterns.

Export Prices by Country

The average export price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, shrinking by X% against the previous year. Overall, the export price saw a deep setback. The most prominent rate of growth was recorded in 2021 an increase of X% against the previous year. Over the period under review, the average export prices attained the peak figure at $X per ton in 2012; however, from 2013 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices for the major foreign markets. In 2022, amid the top suppliers, the country with the highest price was Azerbaijan ($X per ton), while the average price for exports to Tajikistan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Azerbaijan (X%), while the prices for the other major destinations experienced mixed trend patterns.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Iran

Imports of other medicaments for therapeutic or prophylactic uses into Iran soared to X tons in 2022, jumping by X% on the previous year's figure. Over the period under review, imports recorded a tangible expansion. The pace of growth was the most pronounced in 2020 when imports increased by X%. As a result, imports attained the peak of X tons. From 2021 to 2022, the growth of imports of remained at a lower figure.

In value terms, imports of other medicaments for therapeutic or prophylactic uses surged to $X in 2022. Overall, imports recorded buoyant growth. The most prominent rate of growth was recorded in 2020 with an increase of X%. As a result, imports reached the peak of $X. From 2021 to 2022, the growth of imports of remained at a somewhat lower figure.

Imports by Country

Slovenia (X tons), Austria (X tons) and India (X tons) were the main suppliers of imports of other medicaments for therapeutic or prophylactic uses to Iran, together comprising X% of total imports. China, France and Switzerland lagged somewhat behind, together accounting for a further X%.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by France (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, France ($X), Slovenia ($X) and Austria ($X) were the largest other medicaments for therapeutic or prophylactic uses suppliers to Iran, with a combined X% share of total imports.

In terms of the main suppliers, France, with a CAGR of X%, recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, increasing by X% against the previous year. Over the period under review, the import price showed a buoyant increase. The pace of growth appeared the most rapid in 2015 an increase of X% against the previous year. As a result, import price attained the peak level of $X per ton. From 2016 to 2022, the average import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was France ($X per ton), while the price for India ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (X%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :